|Year : 2016 | Volume
| Issue : 5 | Page : 638-642
Characteristics of children and adolescents at onset of type 2 diabetes in a Tertiary Hospital in Bangladesh
Bedowra Zabeen1, Jebun Nahar2, Samin Tayyeb1, Fauzia Mohsin2, Nazmun Nahar2, Kishwar Azad1
1 Department of Changing Diabetes in Children; Department of Paediatrics, Bangladesh Institute of Research and Rehabilitation of Diabetes, Endocrine and Metabolic Disorders, Dhaka, Bangladesh
2 Department of Paediatrics, Bangladesh Institute of Research and Rehabilitation of Diabetes, Endocrine and Metabolic Disorders, Dhaka, Bangladesh
|Date of Web Publication||14-Sep-2016|
Department of Changing Diabetes in Children; Department of Paediatrics, Bangladesh Institute of Research and Rehabilitation of Diabetes, Endocrine and Metabolic Disorders, Dhaka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Introduction: Recent data show that the prevalence of diabetes among children and adolescents is increasing in some ethnic groups. The worldwide epidemic of childhood obesity has been accompanied by an increase in the incidence of type 2 diabetes (T2D) in youth. Methods: The aim of this study was to describe the baseline characteristics of children and adolescents diagnosed ≤18 years who had features of T2D and presented at Changing Diabetes in Children, Paediatric Diabetes Clinic at Bangladesh Institute of Research and Rehabilitation of Diabetes, Endocrine, and Metabolic Disorders. All patients who were newly diagnosed and came to the clinic from March 2011 to March 2015 were included. Results: Among 939 newly registered patients, 77 (8%) had a diagnosis of T2D. The age at diagnosis was 9-10 years in 11 patients (14%), 11-14 years in 46 (60%) and 15-17 years in other 20 patients (26%). Majority of the children had a positive family history of T2D (94%) and 58% were obese. Median fasting insulin (27.9 [17.3-99.3]) was high in 76% patients. Insulin was started initially along with metformin in 40 patients and could be stopped in six patients in 3 months. Conclusion: Our study reflects that T2D is emerging as a problem in children and adolescents in Bangladesh.
Keywords: Bangladesh, children and adolescents, type 2 diabetes
|How to cite this article:|
Zabeen B, Nahar J, Tayyeb S, Mohsin F, Nahar N, Azad K. Characteristics of children and adolescents at onset of type 2 diabetes in a Tertiary Hospital in Bangladesh. Indian J Endocr Metab 2016;20:638-42
|How to cite this URL:|
Zabeen B, Nahar J, Tayyeb S, Mohsin F, Nahar N, Azad K. Characteristics of children and adolescents at onset of type 2 diabetes in a Tertiary Hospital in Bangladesh. Indian J Endocr Metab [serial online] 2016 [cited 2020 Nov 28];20:638-42. Available from: https://www.ijem.in/text.asp?2016/20/5/638/190544
| Introduction|| |
Type 1 diabetes (T1D) is one of the most common chronic diseases among children and adolescents. Type 2 diabetes (T2D) is not common in children and regarded as a disease of adults and occurs most often during the second decade of life. However, recent data show that the prevalence among children and adolescents is increasing in some ethnic groups. ,,, The worldwide epidemic of childhood obesity has been accompanied by an increase in the incidence of T2D in youth, which now accounts for 8-45% of new pediatric cases in urban diabetes centers. ,,, It is of more concern that T2D was seen initially in older children and now prediabetes and diabetes have become encountered in even younger children. In a study done in school-going children in India, the prevalence of prediabetes was 3.7%.  The prevalence of IFG (95% CI) was 3.4% (2.63 - 4.17) and T2DM was 1.8% (1.23 - 2.37) in a study done in different schools in Bangladesh.  The global increase in incidence has become a major concern now and obesity, lack of physical activity, and sedentary life style might have a causative role. The development of T2D in early age is likely to be associated with earlier development of complications. As because comorbid characteristics of insulin resistance are commonly present at diagnosis or appear early in the course of T2D, they should be screened earlier than T1D where these disorders are generally seen as complications of long-standing diabetes rather than as comorbid condition. ,,
To the best of our knowledge, there is hardly any specific study on clinical characteristics of T2D in children and adolescents in our country. We aimed to determine the baseline characteristics of T2D in children and adolescents who are coming for follow-up in Changing Diabetes in children (CDiC) Diabetes Clinic in Bangladesh Institute of Research and Rehabilitation of Diabetes, Endocrine, and Metabolic Disorders (BIRDEM), the largest Paediatric Diabetic Center in Bangladesh.
| Methods|| |
This observational cross-sectional study was done with children and adolescents diagnosed at ≤18 years who had features of T2D (n = 77) presented at CDiC Paediatric Diabetes Clinic at BIRDEM, a Tertiary Care Hospital in Bangladesh. These patients were newly diagnosed who came to the clinic from March 2011 to March 2015. All patients had measurements of fasting and 2 h postprandial plasma glucose with 1.75 g/kg or 75 g of glucose; diabetes mellitus was diagnosed as fasting plasma glucose (FPG) ≥7 mmol/L or 2 h postglucose load ≥11.1 mmol/L. 
In a resource-limited developing country like Bangladesh, C-peptide, antibody or insulin level are not routinely done to classify the type of diabetes rather classify on clinical basis.
The following criteria were considered in diagnosing T2D:
CDiC is a dedicated Paediatric Diabetes Clinic with multidisciplinary team managing diabetes in children and adolescents. This clinic gets referrals from all parts of Bangladesh, as services are provided at subsidized cost or with nominal fees. Informed consent was obtained from the parents to use the data of the children and adolescents and the family members for scientific purposes.
- Presence of obesity or overweight
- Positive family history
- Presence of acanthosis nigricans
- Other features of metabolic syndrome, for example, polycystic ovary syndrome and dyslipidemia
- Availability of fasting insulin level.
Details of demographic and clinical history were recorded. We looked for acanthosis nigricans in all patients. Blood pressure was measured by auscultation after 5 min of rest, and hypertension was diagnosed when blood pressure was ≥95 th percentile for age and sex. 
The body mass index (BMI) was calculated as weight in kilogram divided by square of the height in meter. BMI was calculated and classified using the cutoff points (≥85 th percentile overweight and ≥95 th percentile as obese) using the Center for Disease Control and Prevention growth chart.  Waist circumference was measured along with height and weight. A cutoff of 0.5 was used to differentiate low waist to height ratio (WHtR) from high WHtR. , Investigations such as fasting blood glucose, glycated hemoglobin (HbA1c), and lipid profile were routinely done in all patients at diagnosis. Estimation of blood glucose and lipid profile was done by enzymatic colorimetric method using multichannel auto analyzer. Total cholesterol >200 mg/dl, triglyceride >150 mg/dl, low-density lipoprotein cholesterol >130 mg/dl, and high-density lipoprotein cholesterol <40 mg/dl were designated abnormal. , Insulin resistance index was determined by homeostatic model and calculated as the product of the fasting plasma insulin level (μUnit/ml) and the FPG level (mmol/l), divided by 22.5.  HbA1c was assessed by Clover A1c using photoelectric method.
Data were processed using the Statistical Package for the Social Sciences (SPSS) (SPSS Inc, Chicago, IL, USA). Summary statistics are reported as mean ± standard deviation if normally distributed or median and interquartile range for skewed data.
| Results|| |
Over 4-year period, 939 patients were registered at CDiC clinic. Among them, 77 (8%) had a diagnosis of T2D. Girls were predominating (female:male - 1.8:1). The age at diagnosis was 9-10 years in 11 patients (14%), 11-14 years in 46 (60%), and 15-17 years in other 20 patients (26%). Majority of the children had a positive family history of T2D (94%); parental history was present in 58 (74%) and 53 (70%) had second degree family history (grandparents with T2D) [Table 1].
|Table 1: Demographic status among children and adolescents with T2D (n=77) |
Click here to view
At diagnosis, 49 patients (63%) had typical and 26 (34%) had atypical symptoms [Table 1]. Among the atypical symptoms, 8% patients had undue fatigability and enuresis and 4% girls had pruritus vulvae. Only two (3%) patients presented with diabetic ketoacidosis. Two patients were asymptomatic who were diagnosed incidentally while tested because of obesity and/or strong family history. Majority of the children had acanthosis nigricans (74%).
Only seven children (9%) had normal weight, 33% was overweight, and 58% were obese [Table 2]. The WHtR was high in all children and adolescents with a mean value of 0.59 ± 0.056 [Table 2].
Twenty-five (32%) patients had hypertension during diagnosis. They were advised to follow-up with weight-reducing dietary advice.
Fasting insulin could be done in only 21 patients (mean - 63.9 ± 72.0) and was high in 76% patients and in others, it was within upper normal range. Isolated hypertriglyceridemia was found in 13%, hypercholesterolemia in 35%, and combined hyperlipidemia in 6% patients.
Life style modification was advised to all, providing emphasis on diet and exercise. Mean HbA1c was 10.6 ± 2.7 at diagnosis. Forty patients had their HbA1c >9 who were in high-risk group and insulin was started initially along with metformin. In other patients, monotherapy (n = 37) with metformin was prescribed. The insulin could be stopped in six patients within 3 months. All of them had symptoms of hypoglycemia. In monotherapy group, metformin was stopped in two patients in 3 months. The HbA1c could be done in 38 patients after 3 months (mean 8.0 ± 2.0) [Table 2].
| Discussion|| |
The highest prevalence of T2D in children has been reported from Japan.  The rising prevalence of the disease has now been reported from various parts of the world including Australia, New Zealand, Japan, Hong Kong, the United Kingdom, Libya, Bangladesh  as well as the Arabian Gulf.  The rising incidence has been attributed to the increasing rate of obesity in children. 
In our study, we found that 8% was T2D in newly diagnosed children with diabetes. It shows the fact that T2D occurs even in the developing countries. In concurrence with the reports from the developed countries, ,,,,,,,, obesity, female sex, parental history of T2D, and pubertal age appeared to be strongly associated with the disease in Asian children.
Rapid urbanization has become a risk factor for T2D. In our study, we found that 86% of cases were from urban area, which is similar to a recent report from Sudan.  As expected, female preponderance was present in our group. ,,
The American Academy of Diabetes recommends for screening overweight in children aged 10 years or more with a family history of diabetes and or signs of insulin resistance for diabetes.  In our group, we found four (5%) patients were diagnosed at 9 years of age, which was similar to a recent report. 
Obesity was present in more than half of our children, which was consistent in a study done in Asian-Indian children.  The sign of insulin resistance such as acanthosis nigricans was common in our patients, a similar finding was reported by Drake et al. and Ehtisham et al. and others. ,,
Hypertension was found to be high (32%), which is consistent with several studies done in T2D. ,,, Hyperlipidemia is a well-known comorbidity in children and adolescents with T2D. Hyperlipidemia is a well-known comorbidity in children and adolescents with T2D. Isolated hypertriglyceridemia (13%), hypercholesterolemia (35%), and combined hyperlipidemia (6%) were found in our patients, hypercholesterolemia in one third and hypertriglyceridemia in more than half patients were found in a study done in Australian youth with T2 D. 
| Conclusion|| |
Although the limitation of the study was small sample size and hospital-based study, it reflects T2D is emerging as a problem in children and adolescents, as the center is the largest diabetic hospital in Bangladesh. Despite the constraints of investigations and facilities to differentiate T1, T2, and MODY, we could diagnose the patients as T2 clinically while insulin was not prescribed in around 50% of the cases and also omitted within 3 months in some of the cases.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila) 1998;37:111-5.
Braun B, Zimmermann MB, Kretchmer N, Spargo RM, Smith RM, Gracey M. Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care 1996;19:472-9.
Drake AJ, Smith A, Betts PR, Crowne EC, Shield JP. Type 2 diabetes in obese white children. Arch Dis Child 2002;86:207-8.
Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care 2003;26:1022-5.
Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005;146:693-700.
Neufeld ND, Raffel LJ, Landon C, Chen YD, Vadheim CM. Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 1998;21:80-6.
Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128 (5 Pt 1):608-15.
Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, et al.
Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective. J Pediatr 2000;136:664-72.
Narayanappa D, Rajani HS, Mahendrappa KB, Prabhakar AK. Prevalence of prediabetes in school-going children. Indian Pediatr 2011;48:295-9.
Mohsin F, Mahbuba S, Begum T, Azad K, Nahar N. Prevalence of impaired glucose tolerance among children and adolescents with obesity. Mymensingh Med J 2012;21:684-90.
Kirpichnikov D, Sowers JR. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab 2001;12:225-30.
Laakso M. Lipids in type 2 diabetes. Semin Vasc Med 2002;2:59-66.
Goldberg IJ. Clinical review 124: Diabetic dyslipidemia: Causes and consequences. J Clin Endocrinol Metab 2001;86:965-71.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999;20 Suppl 1:S5.
Report of the Second Task Force on Blood Pressure Control in Children-1987. National Heart, Lung and Blood Institute, Bethesda, MD. Pediatrics 1987;79:1-25.
Kuczmarski RJ, Oglen CL, Grummer Strawn LM. CDC Growth Charts; United States - Advance data. Washington, DC: Center for Disease Control and Prevention/National Center for Health Statistics; 2000;314:1-28.
Maffeis C, Banzato C, Talamini G; Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr 2008;152:207-13.
McCarthy HD, Ashwell M. A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message - 'Keep your waist circumference to less than half your height'. Int J Obes (Lond) 2006;30:988-92.
Boyd GS, Koenigsberg J, Falkner B, Gidding S, Hassink S. Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics 2005;116:442-6.
Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda MD: National Heart, Lung and Blood Institute; 2001.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
Kida K. Obesity and type II diabetes in childhood. In: Proceedings of Diabetes in Asia. Colombo, Sri Lanka: Diabetes Association of Sri Lanka; 2002. p. 44.
Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: Epidemiological evidence. J Pediatr Endocrinol Metab 2000;13 Suppl 6:1395-402.
Punnose J, Agarwal MM, Bin-Uthman S. Type 2 diabetes mellitus among children and adolescents in Al-Ain: A case series. East Mediterr Health J 2005;11:788-97.
Bloomgarden ZT. New insights in obesity. Diabetes Care 2002;25:789-95.
Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children - An emerging problem. Diabet Med 2000;17:867-71.
Matthews DR, Wallace TM. Children with type 2 diabetes: The risks of complications. Horm Res 2002;57 Suppl 1:34-9.
Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al.
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
Arslanian S. Type 2 diabetes in children: Clinical aspects and risk factors. Horm Res 2002;57 Suppl 1:19-28.
American Diabetes Association. Type 2 Diabetes in children and adolescents. Pediatrics 2000;105:671-80.
Osman HA, Elsadek N, Abdullah MA. Type 2 diabetes in Sudanese children and adolescents. Sudanese J Paediatr 2013;13:17-23.
SEARCH for Diabetes in Youth Study Group, Liese AD, D'Agostino RB Jr., Hamman RF, Kilgo PD, Lawrence JM, et al.
The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118:1510-8.
Oeltmann JE, Liese AD, Heinze HJ, Addy CL, Mayer-Davis EJ. Prevalence of diagnosed diabetes among African-American and non-Hispanic white youth, 1999. Diabetes Care 2003;26:2531-5.
Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al.
Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J Clin Endocrinol Metab 2011;96:159-67.
Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, et al.
Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006;29:1300-6.
West NA, Hamman RF, Mayer-Davis EJ, D'Agostino RB Jr., Marcovina SM, Liese AD, et al.
Cardiovascular risk factors among youth with and without type 2 diabetes: Differences and possible mechanisms. Diabetes Care 2009;32:175-80.
Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB Jr, Liese AD, Bell RA, et al.
Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: Implications of a factor analysis of clustering. Metab Syndr Relat Disord 2009;7:89-95.
[Table 1], [Table 2]
|This article has been cited by|
||Clinical features, biochemistry and HLA-DRB1 status in children and adolescents with diabetes in Dhaka, Bangladesh
| ||Bedowra Zabeen,Denira Govender,Zahid Hassan,Janelle Annette Noble,Julie A Lane,Steven John Mack,Mark Alvin Atkinson,Kishwar Azad,Clive Henry Wasserfall,Graham David Ogle |
| ||Diabetes Research and Clinical Practice. 2019; : 107894 |
|[Pubmed] | [DOI]|